X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (381) 381
humans (367) 367
female (207) 207
male (199) 199
middle aged (164) 164
risk factors (125) 125
adult (124) 124
combined modality therapy (108) 108
aged (106) 106
endocrinology & metabolism (92) 92
familial combined hyperlipidemia (86) 86
diabetes (71) 71
cholesterol (65) 65
treatment outcome (65) 65
combined hyperlipidemia (60) 60
medicine, general & internal (59) 59
coronary-heart-disease (58) 58
type 2 diabetes (54) 54
cardiovascular-disease (51) 51
lipids (51) 51
cardiovascular disease (50) 50
atherosclerosis (49) 49
hypolipidemic agents - therapeutic use (49) 49
obesity (49) 49
insulin resistance (48) 48
metabolic syndrome (46) 46
risk (46) 46
animals (44) 44
care and treatment (44) 44
triglycerides (44) 44
insulin-resistance (43) 43
triglycerides - blood (43) 43
adolescent (42) 42
cardiovascular diseases - prevention & control (42) 42
peripheral vascular disease (42) 42
cardiac & cardiovascular systems (41) 41
pharmacology & pharmacy (41) 41
analysis (40) 40
metabolism (37) 37
cholesterol, ldl - blood (36) 36
glucose (36) 36
statins (36) 36
cardiovascular diseases (35) 35
diabetes mellitus, type 2 - blood (35) 35
hypoglycemic agents - therapeutic use (34) 34
medicine, research & experimental (34) 34
body mass index (33) 33
density-lipoprotein cholesterol (33) 33
internal medicine (33) 33
myocardial-infarction (33) 33
cardiovascular diseases - etiology (32) 32
coronary-artery-disease (32) 32
health aspects (32) 32
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (32) 32
hypertension (32) 32
research (32) 32
cholesterol, hdl - blood (31) 31
diabetes mellitus, type 2 - complications (31) 31
follow-up studies (31) 31
life style (31) 31
lipids - blood (31) 31
double-blind method (30) 30
dyslipidemias - drug therapy (30) 30
exercise (30) 30
hypercholesterolemia (30) 30
mortality (30) 30
biomarkers - blood (29) 29
cholesterol - blood (29) 29
diabetes mellitus, type 2 - drug therapy (29) 29
genetic aspects (29) 29
lipoproteins (29) 29
physiological aspects (29) 29
risk-factors (29) 29
therapy (29) 29
atorvastatin (28) 28
diabetes mellitus (28) 28
dyslipidemia (28) 28
low density lipoproteins (28) 28
medicine & public health (28) 28
cardiovascular diseases - epidemiology (27) 27
diabetes mellitus, type 2 - therapy (27) 27
dyslipidaemia (27) 27
prevention (27) 27
drug therapy, combination (26) 26
fenofibrate (26) 26
hyperlipidemia (26) 26
diet (25) 25
insulin (25) 25
low-density-lipoprotein (25) 25
management (25) 25
drug therapy (24) 24
dyslipidemias - blood (24) 24
simvastatin (24) 24
studies (24) 24
aged, 80 and over (23) 23
child (23) 23
clinical trials (23) 23
double-blind (23) 23
heart-disease (23) 23
prevalence (23) 23
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1995, Baillière's clinical endocrinology and metabolism, ISBN 0702019828, Volume 9, no. 4., x, p. 687-895
Book
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9582, pp. 153 - 160
Summary Background Patients with mixed dyslipidaemia have raised triglycerides, low high-density lipoprotein (HDL) cholesterol, and high low-density... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | METABOLIC SYNDROME | COMBINED HYPERLIPIDEMIA | ESTER TRANSFER PROTEIN | CHOLESTEROL LEVELS | CARDIOVASCULAR-DISEASE | ATHEROSCLEROSIS | HDL CHOLESTEROL | CORONARY-HEART-DISEASE | SECONDARY PREVENTION | HIGH-DENSITY-LIPOPROTEIN | Carotid Arteries - drug effects | Dyslipidemias - drug therapy | Double-Blind Method | Cholesterol - blood | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Heptanoic Acids - adverse effects | Anticholesteremic Agents - adverse effects | Tunica Intima - drug effects | Atorvastatin Calcium | Dyslipidemias - blood | Anticholesteremic Agents - therapeutic use | Tunica Intima - pathology | Pyrroles - adverse effects | Female | Blood Pressure - drug effects | Quinolines - therapeutic use | Pyrroles - therapeutic use | Quinolines - adverse effects | Studies | Medical research | Digital imaging | Diet | Mortality | Cardiovascular disease | Metabolic syndrome | Protocol | Low density lipoprotein | Patients | Cholesterol | Veins & arteries | Lipoproteins (low density) | Laboratories | Clinical trials | Segments | Density | Carotid arteries | Blood | Proteins | Randomization | Ultrasonic imaging | Radiance | Atherosclerosis | Blood pressure | Lipoproteins (high density) | Ultrasound | Media | Triglycerides | Cholesteryl ester transfer protein | Arteriosclerosis | Atorvastatin | Titration | Diabetes | Health risk assessment | Mercury | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Endocrinology, Metabolism and Diabetes of South Africa, ISSN 1608-9677, 09/2017, Volume 22, Issue 3, pp. 31 - 35
Background: Diabetes mellitus (DM) is a common secondary cause of dyslipidaemia, particularly if glycaemic control is poor, which in turn is an important risk... 
lipid targets | LDL | combined dyslipidaemia
Journal Article
MEDICINA-LITHUANIA, ISSN 1010-660X, 07/2019, Volume 55, Issue 7, p. 392
Background and Objectives: Dyslipidaemia and its associated complications have been reported to increase mortality among type 2 diabetes mellitus (T2DM)... 
METABOLIC SYNDROME | gender | PREVALENCE | FAMILY-HISTORY | MEDICINE, GENERAL & INTERNAL | OBESITY | family history | INSULIN-RESISTANCE | DISEASE | BLOOD-PRESSURE CONTROL | combined dyslipidemia | MIXED DYSLIPIDEMIA | HYPERTENSION | diabetes | ASSOCIATION | BMI
Journal Article
Diabetes & Vascular Disease Research, ISSN 1479-1641, 1/2014, Volume 11, Issue 1, pp. 26 - 33
In this prospective study, we examined the effect of atorvastatin treatment on baroreflex sensitivity (BRS) in subjects with type 2 diabetes. A total of 79... 
baroreflex sensitivity | Atorvastatin | diabetes | autonomic function | C-REACTIVE PROTEIN | SPONTANEOUSLY HYPERTENSIVE-RATS | TIME-DOMAIN | NITRIC-OXIDE SYNTHASE | REFLEX SENSITIVITY | AUTONOMIC NEUROPATHY | BLOOD-PRESSURE | CARDIOVASCULAR REGULATION | ENDOCRINOLOGY & METABOLISM | PERIPHERAL VASCULAR DISEASE | DYSFUNCTION | REDUCES SYMPATHETIC ACTIVITY | Prospective Studies | Diabetic Cardiomyopathies - etiology | Dyslipidemias - complications | Myalgia - chemically induced | Cardiovascular Diseases - prevention & control | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Diabetic Angiopathies - etiology | Male | Heptanoic Acids - adverse effects | Patient Dropouts | Cardiovascular Diseases - complications | Cardiovascular Diseases - epidemiology | Pyrroles - adverse effects | Diabetic Angiopathies - complications | Diabetic Cardiomyopathies - prevention & control | Female | Diabetic Angiopathies - prevention & control | Pyrroles - therapeutic use | Diabetes Mellitus, Type 2 - complications | Body Mass Index | Cardiovascular Diseases - etiology | Dyslipidemias - drug therapy | Obesity - complications | Risk Factors | Diabetic Cardiomyopathies - complications | Greece - epidemiology | Combined Modality Therapy - adverse effects | Baroreflex - drug effects | Atorvastatin Calcium | Cardiovascular Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Diabetic Cardiomyopathies - epidemiology | Diet, Fat-Restricted | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Diabetic Angiopathies - epidemiology | Aged | Cardiovascular Agents - adverse effects | Dyslipidemias - diet therapy | Dyslipidemias - physiopathology | Index Medicus
Journal Article
Journal Article
Archives of Medical Science, ISSN 1734-1922, 12/2010, Volume 6, Issue 6, pp. 879 - 886
Journal Article
Journal of Evidence Based Medicine and Healthcare, ISSN 2349-2562, 07/2019, Volume 6, Issue 29, pp. 1978 - 1982
BACKGROUND Diabetes mellitus (DM) is a common secondary cause of dyslipidaemia, particularly if glycaemic control is poor, and can be an important risk factor... 
HDL | Lipid Targets | Dyslipidaemia | Combined Dyslipidaemia | Diabetes Mellitus | Hypertriglyceridemia
Journal Article
Journal Article
Heart, ISSN 1355-6037, 09/2002, Volume 88, Issue 3, pp. 234 - 238
Journal Article
European Heart Journal, Supplement, ISSN 1520-765X, 07/2005, Volume 7, Issue F, pp. F56 - F62
Journal Article